1. انتشارات جعفری نوین
  2. لاتین
  3. خون و سرطان - Hematology & Oncology
  4. Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncologyمدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان
Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncologyمدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان Springer
Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncologyمدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان Springer Springer  

Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncologyمدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان

کد کتاب 143369

Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncology

مدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان

افست = اورجینال
چاپ تمام رنگی

کاغذ 80 گرمی اندونزی
جلد سخت و ته دوخت

*بهترین کیفیت افست را از ما بخواهید*

این کتاب برای متخصصان قلب بالینی و سایر پزشکانی که با بیماران قلبی کار می کنند طراحی شده است ، جایی که تیم های تخصصی متخصص قلب و عروق در دسترس نیستند و برای ارزیابی وضعیت قلبی و صلاحیت شیمی درمانی یا پرتودرمانی برای انجام مشاوره بالینی فراخوانده شده اند .

تعداد صفحه
259
چاپ
زبان
سال نشر
شابک
قطع

خرید Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncologyمدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان

دارای 5% تخفیف  

Cardiac Management of Oncology Patients : Clinical Handbook for Cardio-Oncology

مدیریت قلبی بیماران انکولوژی: راهنمای بالینی برای قلب و سرطان

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them

Product details

  • Paperback | 259 pages
  • 155 x 235 x 14.48mm | 4,656g
  • Cham, Switzerland
  • English
  • 2015 ed.
  • 58 Illustrations, color; 7 Illustrations, black and white; IX, 259 p. 65 illus., 58 illus. in color.
  • 3319158074
  • 9783319158075